SHAREHOLDER ALERT: AMPE LCI PZZA SKX PM USAT COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Ampio Pharmaceuticals, Inc. AMPE

Lead Plaintiff Deadline: October 24, 2018

Class Period: December 14, 2017 and August 7, 2018

Get additional information about AMPE: http://www.wongesq.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3

Lannett Company, Inc. LCI

Lead Plaintiff Deadline: October 26, 2018

Class Period: February 7, 2018 and August 17, 2018

Get additional information about LCI: http://www.wongesq.com/pslra-1/lannett-company-inc-loss-submission-form?wire=3

Papa John's International, Inc. PZZA

Lead Plaintiff Deadline: October 29, 2018

Class Period: February 25, 2014 and July 19, 2018

Get additional information about PZZA: http://www.wongesq.com/pslra-1/papa-johns-international-inc-submission-form?wire=3

Skechers U.S.A., Inc. SKX

Lead Plaintiff Deadline: November 5, 2018

Class Period: October 20, 2017 and July 19, 2018

Get additional information about SKX: http://www.wongesq.com/pslra-1/skechers-u-s-a-inc-loss-submission-form?wire=3

Philip Morris International, Inc.  PM

Lead Plaintiff Deadline: November 5, 2018

Class Period: July 26, 2016 and April 18, 2018

Get additional information about PM: http://www.wongesq.com/pslra-1/philip-morris-international-inc-loss-submission-form?wire=3

USA Technologies, Inc. USAT

Lead Plaintiff Deadline: November 13, 2018

Class Period: November 9, 2017 and September 11, 2018

Get additional information about USAT: http://www.wongesq.com/pslra-1/usa-technologies-inc-loss-submission-form?wire=3

Cocrystal Pharma, Inc. COCP

Lead Plaintiff Deadline: November 19, 2018

Class Period: September 23, 2013 and September 7, 2018

Get additional information about COCP: http://www.wongesq.com/pslra-1/cocrystal-pharma-inc-f-k-a-biozone-pharmaceuticals-loss-submission-form?wire=3

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.

39 East Broadway

Suite 304

New York, NY 10002

Tel. 212.425.1140

Fax. 866.699.3880

E-Mail: vw@wongesq.com